- Home
- IRBT vs MCRB Comparison
IRBT vs MCRB Comparison
Compare IRBT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- MCRB
- Stock Information
- Founded
- IRBT 1990
- MCRB 2010
- Country
- IRBT United States
- MCRB United States
- Employees
- IRBT N/A
- MCRB N/A
- Industry
- IRBT Consumer Electronics/Appliances
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- IRBT Consumer Discretionary
- MCRB Health Care
- Exchange
- IRBT Nasdaq
- MCRB Nasdaq
- Market Cap
- IRBT 168.4M
- MCRB 144.6M
- IPO Year
- IRBT N/A
- MCRB 2015
- Fundamental
- Price
- IRBT $4.63
- MCRB $18.91
- Analyst Decision
- IRBT Hold
- MCRB Hold
- Analyst Count
- IRBT 1
- MCRB 4
- Target Price
- IRBT N/A
- MCRB $14.33
- AVG Volume (30 Days)
- IRBT 3.2M
- MCRB 123.5K
- Earning Date
- IRBT 11-04-2025
- MCRB 11-12-2025
- Dividend Yield
- IRBT N/A
- MCRB N/A
- EPS Growth
- IRBT N/A
- MCRB N/A
- EPS
- IRBT N/A
- MCRB 10.22
- Revenue
- IRBT $594,601,000.00
- MCRB N/A
- Revenue This Year
- IRBT N/A
- MCRB N/A
- Revenue Next Year
- IRBT $69.39
- MCRB N/A
- P/E Ratio
- IRBT N/A
- MCRB $1.93
- Revenue Growth
- IRBT N/A
- MCRB N/A
- 52 Week Low
- IRBT $1.76
- MCRB $6.53
- 52 Week High
- IRBT $13.06
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- IRBT 57.47
- MCRB 53.18
- Support Level
- IRBT $4.36
- MCRB $18.72
- Resistance Level
- IRBT $6.10
- MCRB $21.50
- Average True Range (ATR)
- IRBT 0.53
- MCRB 1.23
- MACD
- IRBT 0.07
- MCRB -0.16
- Stochastic Oscillator
- IRBT 42.72
- MCRB 30.61
About IRBT iRobot Corporation
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.